EUVIMEDEUVIMED entdecken
Crossref

Limonin mitigates hepatic senescence and fibrosis in MASH mice by targeting STAT3 to inhibit Galectin-3/mTORC1 signaling

Tian Lan, Wen Wang, Xi-Xi Zeng, Wei-Li Mao, Tao Lu, Si-Wei Wang

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Tian Lan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Mechanistic Target of Rapamycin Complex 1, Galectin 3, Liver Cirrhosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Quzhou Municipal Science and Technology Bureau, Zhejiang Administration Bureau of Traditional Chinese Medicine, Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite existing reports on the hepatoprotective effects of limonin (Lim), its specific impact on hepatic fibrosis and cellular senescence in metabolic dysfunction-associated steatohepatitis (MASH) remains unclear. The precise molecular mechanisms and direct targets underpinning its pharmacological activity are also poorly defined. PURPOSE: This research aimed to investigate the therapeutic potential of Lim against MASH-related hepatic fibrosis and senescence, and to delineate the underlying molecular pathways. METHODS: A murine MASH model was generated by feeding a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD). To elucidate the mechanism of action of Lim, an integrated strategy was adopted, comprising AAV8-mediated gene manipulation, RNA sequencing (RNA-seq), and pharmacological interventions with agonists or inhibitors. The direct protein targets of Lim were identified using human proteome microarrays and validated through molecular docking, pull-down assays, and site-directed mutagenesis. RESULTS: Our findings indicate that Lim effectively alleviates hepatic fibrosis and senescence in MASH mice, while suppressing galectin-3 expression and mechanistic target of rapamycin complex 1 (mTORC1) activation. Notably, targeted knockdown of galectin-3 in the liver hindered aging-related changes in MASH mice, with mTORC1 functioning as a downstream effector. Further results revealed that mTORC1 acts as a key mediator of Lim's protective effects against hepatic fibrosis and senescence in MASH mice. Mechanistically, Lim binds to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (STAT3), inhibiting its activity and leading to reduced galectin-3 expression and mTORC1 activation. Moreover, the application of STAT3 inhibitor has been shown to alleviate hepatic fibrosis and senescence in MASH mice, further corroborating the suppression of galectin-3 and mTORC1 activity. CONCLUSION: In conclusion, our study provides compelling evidence for the efficacy of Lim in ameliorating hepatic senescence and fibrosis in MASH mice, elucidating the involvement of the STAT3/galectin-3/mTORC1 signaling in these processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorMechanistic Target of Rapamycin Complex 1Galectin 3Liver CirrhosisLimoninsFatty LiverCellular SenescenceAnimalsSignal TransductionMiceMaleMice, Inbred C57BLLiverHumansDisease Models, AnimalDiet, High-Fat

Stichwörter der Autor:innen

Hepatic senescenceLimoninMASHSTAT3galectin-3mTORC1

Substanzen

STAT3 Transcription FactorMechanistic Target of Rapamycin Complex 1Galectin 3Stat3 protein, mouseLimoninslimoninLgals3 protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacy, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.
  • Zhejiang Chinese Medical University Affiliated Four-provinces Marginal Hospital of Traditional Chinese Medicine, Quzhou Hospital of Traditional Chinese Medicine, Quzhou 324000, China.
  • Department of Infectious Diseases, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China. Electronic address: zjqzlutao@163.com.
  • Department of Pharmacy, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China. Electronic address: wsw_1972@wmu.edu.cn.

Förderung

  • Quzhou Municipal Science and Technology Bureau
  • Zhejiang Administration Bureau of Traditional Chinese Medicine
  • Medical Science and Technology Project of Zhejiang Province
  • Zhejiang Province Natural Science Foundation

Zitieren

APA

Lan, T., Wang, W., Zeng, X. X., Mao, W. L., Lu, T., & Wang, S. W. (2026). Limonin mitigates hepatic senescence and fibrosis in MASH mice by targeting STAT3 to inhibit Galectin-3/mTORC1 signaling. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158244

Vancouver

Lan T, Wang W, Zeng XX, Mao WL, Lu T, Wang SW. Limonin mitigates hepatic senescence and fibrosis in MASH mice by targeting STAT3 to inhibit Galectin-3/mTORC1 signaling. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158244

BibTeX
@article{Lan2026,
  author = {Lan, Tian and Wang, Wen and Zeng, Xi-Xi and Mao, Wei-Li and Lu, Tao and Wang, Si-Wei},
  title = {Limonin mitigates hepatic senescence and fibrosis in MASH mice by targeting STAT3 to inhibit Galectin-3/mTORC1 signaling},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158244}
}
Kostenlos starten →